ELCO Management’s Core Laboratories CLB Stock Holding History

ELCO Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-6,000	Closed	-$314K	–	154
2019 Q2	$314K	Hold	6,000	–	–	0.17%	121
2019 Q1	$414K	Hold	6,000	–	–	0.24%	91
2018 Q4	$358K	Sell	6,000 -4,100	-41%	-$354K	0.24%	94
2018 Q3	$1.17M	Hold	10,100	–	–	0.62%	52
2018 Q2	$1.27M	Hold	10,100	–	–	0.69%	46
2018 Q1	$1.09M	Hold	10,100	–	–	0.64%	52
2017 Q4	$1.11M	Sell	10,100 -150	-1%	-$15K	0.61%	53
2017 Q3	$1.01M	Hold	10,250	–	–	0.57%	57
2017 Q2	$1.04M	Hold	10,250	–	–	0.61%	53
2017 Q1	$1.18M	Buy	10,250 +50	+0.5%	+$5.81K	0.63%	57
2016 Q4	$1.22M	Sell	10,200 -10,100	-50%	-$1.12M	0.68%	50
2016 Q3	$2.28M	Buy	+20,300	New	+$2.34M	0.91%	35

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

ELCO Management's CLB Position: Q3 2019 in Review

ELCO Management sold out of Core Laboratories (CLB) in Q3 2019, closing a stake of 6,000 shares — an estimated $314K sold.

ELCO Management first reported a position in CLB in Q3 2016 and held it in 12 quarters. The position peaked at $2.28M in Q3 2016. 274 funds tracked by Wall St. Rank hold CLB as of Q3 2019.

ELCO Management reported no remaining Core Laboratories position as of Q3 2019 after selling out during the quarter.
ELCO Management sold 6,000 Core Laboratories shares in Q3 2019, an estimated $314K.
ELCO Management first reported a position in Core Laboratories in Q3 2016 and held it in 12 quarters.
ELCO Management's Core Laboratories position peaked at $2.28M in Q3 2016.
274 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2019.

Based on ELCO Management's 13F filing for Q3 2019, filed 14 Nov 2019.